Ovarian cancer drugs market to reach $11.53 billion by 2030 at 14.8% cagr, driven by government initiatives and funding for ovarian cancer research.
Read More
Otic drugs market to reach $2.59 billion by 2030 at 7.5% cagr, driven by rising prevalence rate of ear infections and hearing-related disorders.
Read More
Otc dry eye drops market to reach $5.33 billion by 2030 at 7.0% cagr, driven by increasing screen exposure and growing digital eye strain.
Read More
Otc drug and dietary supplement market to reach $497.84 billion by 2030 at 7.2% cagr, driven by rising pharma research and development expenditure globally.
Read More
Osteoporosis drugs market to reach $16.21 billion by 2030 at 4.3% cagr, driven by surging prevalence of osteoporosis among aging populations worldwide.
Read More
Osteogenesis imperfecta treatment market to reach $1.16 billion by 2030 at 4.3% cagr, driven by increasing prevalence of osteogenesis imperfecta due to improved genetic diagnosis.
Read More
Osimertinib drugs market to reach $16.25 billion by 2030 at 16.1% cagr, driven by increasing incidence of lung cancer and rising organizational initiatives to improve cancer care.
Read More
Orphan drugs service market to reach $93.93 billion by 2030 at 16.6% cagr, driven by growing investment in rare diseases and increased funding for research and development.
Read More
Orphan drugs market to reach $794.12 billion by 2030 at 28.2% cagr, driven by rising prevalence of rare diseases globally and increasing diagnosis rates.
Read More
Organic pharmaceutical excipients market to reach $18.99 billion by 2030 at 9.3% cagr, driven by rising demand for pharmaceutical drugs due to growing burden of chronic and complex health conditions.
Read More